Berberine and Curcumin Target Survivin and STAT3 in Gastric Cancer Cells and Synergize Actions of Standard Chemotherapeutic 5-Fluorouracil

Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer

(2014) Marcelo Garrido et al.   Expert Review of Anticancer Therapy

Curcumin, a component of turmeric: From farm to pharmacy

(2013) Subash C. Gupta et al.   BIOFACTORS

Unshackling caspase-7 for cancer therapy

(2013) Maria Eugenia Guicciardi et al.   JOURNAL OF CLINICAL INVESTIGATION

Curcumin Enhances the Effect of Chemotherapy against Colorectal Cancer Cells by Inhibition of NF-κB and Src Protein Kinase Signaling Pathways

(2013) Mehdi Shakibaei et al.   PLoS One

Functional Regulatory Role of STAT3 in HPV16-Mediated Cervical Carcinogenesis

(2013) Shirish Shukla et al.   PLoS One

Anticancer property of Bryophyllum pinnata (Lam.) Oken. leaf on human cervical cancer cells

(2012) Sutapa Mahata et al.   BMC Complementary and Alternative Medicine

Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration

(2012) Jonathan Michaud-Levesque et al.   EXPERIMENTAL CELL RESEARCH

The Formation and Stabilization of a Novel G-Quadruplex in the 5′-Flanking Region of the Relaxin Gene

(2012) Sen Lin et al.   PLoS One

YM155 Induces EGFR Suppression in Pancreatic Cancer Cells

(2012) Young-Soon Na et al.   PLoS One

Berberine as a Promising Safe Anti-Cancer Agent- Is there a Role for Mitochondria?

(2011) Catia V. Diogo et al.   CURRENT DRUG TARGETS

Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells

(2011) Sutapa Mahata et al.   Molecular Cancer

Constitutive Activation of Signal Transducers and Activators of Transcription 3 Correlates with Better Prognosis, Cell Proliferation and Hypoxia-Inducible Factor-1α in Human Gastric Cancer

(2011) Sungmin Woo et al.   PATHOBIOLOGY

Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection

(2010) Shirish Shukla et al.   Molecular Cancer

Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors

(2009) T. Satoh et al.   CLINICAL CANCER RESEARCH

Increased Survivin Expression Confers Chemoresistance to Tumor-Associated Endothelial Cells

(2008) Jenilyn J. Virrey et al.   AMERICAN JOURNAL OF PATHOLOGY

Berberine, a Natural Product, Combined with Cisplatin Enhanced Apoptosis through a Mitochondria/Caspase-Mediated Pathway in HeLa Cells

(2008) Myung-Ja Youn et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Knockdown of Survivin and Upregulation of p53 Gene Expression by Small Interfering RNA Induces Apoptosis in Human Gastric Carcinoma Cell Line SGC-823

(2008) Yun-Hua Lu et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin

(2008) Anthony W. Tolcher et al.   JOURNAL OF CLINICAL ONCOLOGY

Combined Targeting of Epidermal Growth Factor Receptor, Signal Transducer and Activator of Transcription-3, and Bcl-XL Enhances Antitumor Effects in Squamous Cell Carcinoma of the Head and Neck

(2008) A. L. Boehm et al.   MOLECULAR PHARMACOLOGY

New wirings in the survivin networks

(2008) D C Altieri   ONCOGENE

Studies on alkaloids binding to GC-rich humansurvivin promoter DNA using positive and negative ion electrospray ionization mass spectrometry

(2007) Zhaofu Wang et al.   JOURNAL OF MASS SPECTROMETRY